A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
375
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Chronic Kidney Disease
Interventions
DRUG:
GCS-100
DRUG:
Placebo
Sponsor
La Jolla Pharmaceutical Company